scholarly journals Treatment Toxicity: Radiation

Author(s):  
Thomas J. FitzGerald ◽  
Maryann Bishop-Jodoin ◽  
Fran Laurie ◽  
Matthew Iandoli ◽  
Ameer Elaimy ◽  
...  
Keyword(s):  
Author(s):  
Emine Acar ◽  
Burak Sönmezer ◽  
Erkan Derebek ◽  
Recep Bekiş ◽  
Özhan Özdoğan ◽  
...  

2019 ◽  
Vol 58 (8) ◽  
pp. 1138-1148 ◽  
Author(s):  
Lok Lam Ngai ◽  
Emil ter Veer ◽  
Héctor G. van den Boorn ◽  
E. Hugo van Herk ◽  
Jessy Joy van Kleef ◽  
...  

2017 ◽  
Vol 12 (11) ◽  
pp. S2083-S2084
Author(s):  
M. Boucher ◽  
L. Mezquita ◽  
E. Auclin ◽  
M. Mons ◽  
J. Marghadi ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-3
Author(s):  
Carrie A. Strauss ◽  
Jeffrey A. Kotzen ◽  
Ans Baeyens ◽  
Irma Maré

Aim. Investigate the clinical, economic, and cellular effects of the addition of oncothermia to standard treatment for HIV-positive and -negative locally advanced cervical cancer patients in public healthcare in South Africa. Objectives. Evaluate the effect that the addition of oncothermia has on local disease control, progression-free survival, overall survival at 2 years, treatment toxicity, quality of life, economic impact, and HIV status of participants. Radiobiology investigations will evaluate thermoradiosensitivity and the molecular markers for thermoradiosensitivity. Methodology. Phase III randomised clinical trial involving 236 HIV-negative and -positive stage IIb-III locally advanced cervical cancer patients. Treatment includes cisplatin, external beam radiation, and brachytherapy. The study group will receive oncothermia treatments. Participants will be monitored for two years after completion of treatment. Hypothesis. The addition of oncothermia to standard treatment protocols will result in improved clinical response without increasing treatment toxicity in HIV-positive patients or raising healthcare costs.


2021 ◽  
Vol 22 (23) ◽  
pp. 12827
Author(s):  
Mahshid Ghasemi ◽  
Tyron Turnbull ◽  
Sonia Sebastian ◽  
Ivan Kempson

The MTT assay for cellular metabolic activity is almost ubiquitous to studies of cell toxicity; however, it is commonly applied and interpreted erroneously. We investigated the applicability and limitations of the MTT assay in representing treatment toxicity, cell viability, and metabolic activity. We evaluated the effect of potential confounding variables on the MTT assay measurements on a prostate cancer cell line (PC-3) including cell seeding number, MTT concentration, MTT incubation time, serum starvation, cell culture media composition, released intracellular contents (cell lysate and secretome), and extrusion of formazan to the extracellular space. We also assessed the confounding effect of polyethylene glycol (PEG)-coated gold nanoparticles (Au-NPs) as a tested treatment in PC-3 cells on the assay measurements. We additionally evaluated the applicability of microscopic image cytometry as a tool for measuring intracellular MTT reduction at the single-cell level. Our findings show that the assay measurements are a result of a complicated process dependant on many of the above-mentioned factors, and therefore, optimization of the assay and rational interpretation of the data is necessary to prevent misleading conclusions on variables such as cell viability, treatment toxicity, and/or cell metabolism. We conclude, with recommendations on how to apply the assay and a perspective on where the utility of the assay is a powerful tool, but likewise where it has limitations.


2019 ◽  
Vol 13 (4) ◽  
pp. 292-297 ◽  
Author(s):  
Shilpa Mukunda Chowdhry ◽  
Varun Kumar Chowdhry

Cancer Cell ◽  
2019 ◽  
Vol 35 (6) ◽  
pp. 821-822 ◽  
Author(s):  
Jan Benada ◽  
Bent Ejlertsen ◽  
Claus Storgaard Sørensen

Sign in / Sign up

Export Citation Format

Share Document